Compare with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ZIM LABORATORIES vs SHREE GANESH REMEDIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ZIM LABORATORIES SHREE GANESH REMEDIES ZIM LABORATORIES/
SHREE GANESH REMEDIES
 
P/E (TTM) x 39.0 35.7 109.3% View Chart
P/BV x 1.5 8.0 19.2% View Chart
Dividend Yield % 0.0 0.5 -  

Financials

 ZIM LABORATORIES   SHREE GANESH REMEDIES
EQUITY SHARE DATA
    ZIM LABORATORIES
Mar-21
SHREE GANESH REMEDIES
Mar-21
ZIM LABORATORIES/
SHREE GANESH REMEDIES
5-Yr Chart
Click to enlarge
High Rs131345 38.1%   
Low Rs5365 81.3%   
Sales per share (Unadj.) Rs189.249.0 386.0%  
Earnings per share (Unadj.) Rs4.59.7 46.2%  
Cash flow per share (Unadj.) Rs14.212.5 114.1%  
Dividends per share (Unadj.) Rs01.75 0.0%  
Avg Dividend yield %00.9 0.0%  
Book value per share (Unadj.) Rs99.050.0 198.2%  
Shares outstanding (eoy) m16.2410.01 162.2%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x0.54.2 11.7%   
Avg P/E ratio x20.521.0 97.3%  
P/CF ratio (eoy) x6.516.4 39.4%  
Price / Book Value ratio x0.94.1 22.7%  
Dividend payout %018.0 0.0%   
Avg Mkt Cap Rs m1,4972,051 73.0%   
No. of employees `000NANA-   
Total wages/salary Rs m35824 1,473.5%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m3,073491 626.2%  
Other income Rs m2321 111.6%   
Total revenues Rs m3,096512 605.1%   
Gross profit Rs m346136 253.4%  
Depreciation Rs m15827 579.4%   
Interest Rs m1091 16,026.5%   
Profit before tax Rs m102129 79.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2932 91.2%   
Profit after tax Rs m7398 75.0%  
Gross profit margin %11.327.8 40.5%  
Effective tax rate %28.524.7 115.4%   
Net profit margin %2.419.9 12.0%  
BALANCE SHEET DATA
Current assets Rs m1,918380 504.8%   
Current liabilities Rs m1,420102 1,394.1%   
Net working cap to sales %16.256.7 28.6%  
Current ratio x1.43.7 36.2%  
Inventory Days Days1636 43.7%  
Debtors Days Days85899,126,372 0.0%  
Net fixed assets Rs m1,304226 576.9%   
Share capital Rs m162100 162.3%   
"Free" reserves Rs m1,445400 361.3%   
Net worth Rs m1,608500 321.5%   
Long term debt Rs m2180-   
Total assets Rs m3,222606 531.7%  
Interest coverage x1.9191.4 1.0%   
Debt to equity ratio x0.10-  
Sales to assets ratio x1.00.8 117.8%   
Return on assets %5.716.2 34.9%  
Return on equity %4.619.5 23.3%  
Return on capital %11.626.0 44.5%  
Exports to sales %67.474.6 90.4%   
Imports to sales %4.123.1 18.0%   
Exports (fob) Rs m2,072366 566.3%   
Imports (cif) Rs m127113 112.6%   
Fx inflow Rs m2,140366 584.7%   
Fx outflow Rs m127113 112.6%   
Net fx Rs m2,012253 796.2%   
CASH FLOW
From Operations Rs m31933 962.0%  
From Investments Rs m-59-9 624.3%  
From Financial Activity Rs m-260-7 3,953.4%  
Net Cashflow Rs m-117 -4.0%  

Share Holding

Indian Promoters % 33.3 69.1 48.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 0.0 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 66.7 30.9 216.1%  
Shareholders   3,646 5,741 63.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ZIM LABORATORIES With:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    



Today's Market

4 Reasons Why Sensex Plunged 634 Points Today(Closing)

Indian share markets witnessed negative trading activity throughout the day today and ended on a weak note.

Related Views on News

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

More Views on News

Most Popular

India's Best Semiconductor Stocks(Views On News)

Jan 7, 2022

Modern wars are fought with semiconductors. India's best semiconductor stocks have big tailwinds from defence and manufacturing.

10 Indian Companies with the Fastest Growth in Dividend Payouts...(Views On News)

Jan 10, 2022

These companies have been consistently paying higher dividends for several years.

Tata Steel vs SAIL: Which Stock is Better?(Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

Watch Out for these 4 Indian Companies Betting Big on EV Supply Chain(Views On News)

Jan 11, 2022

The upside in supply chain players could be huge but a delay in the transition to EVs, or any policy related hiccups could end the momentum.

Tech Mahindra's CTC Acquisition: Too Expensive?(Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ZIM LABORATORIES SHARE PRICE


Jan 20, 2022 (Close)

TRACK ZIM LABORATORIES

  • Track your investment in ZIM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ZIM LABORATORIES

ZIM LABORATORIES 8-QTR ANALYSIS

COMPARE ZIM LABORATORIES WITH

MARKET STATS